Granulocyte Colony Stimulating Factor (G-CSF)
Granulocyte Colony Stimulating Factor (G-CSF) is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
5
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
G-CSF After Chemo-radiation in Patients With Glioblastoma
M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)
ATG-GCSF in New Onset Type 1 Diabetes
Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy
Clinical Trials (6)
G-CSF After Chemo-radiation in Patients With Glioblastoma
M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)
ATG-GCSF in New Onset Type 1 Diabetes
Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy
Influence of G-CSF and EPO on Associative Learning and Motor Skills
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6